| Andrew Gerodias, LMHC TEMP, CADC | |
|
3320 W 4th St, Sioux City, IA 51103-3200 | |
| (712) 202-0777 | |
| (712) 202-0780 |
| Full Name | Andrew Gerodias |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 3320 W 4th St, Sioux City, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073975389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 14020 (Iowa) | Secondary |
| 101YM0800X | Counselor - Mental Health | 079514 (Iowa) | Primary |
| Entity Name | Jackson Recovery Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811994973 PECOS PAC ID: 2466599634 Enrollment ID: O20091020000508 |
News Archive
Driven by increasing demand from drug and medical device developers for cost-effective and user-friendly data analytics tools, Comprehend Systems, Inc. closed $1.2 million in seed round funding to support further development of Comprehend Clinical, its clinical data visualization and analytics software.
"From President John F. Kennedy to President Barack Obama, the United States has a rich history of providing assistance that improves the lives of men, women and children around the globe. Today President Obama issued the first-ever development policy by a U.S. President. In partnership with the host countries where we work, USAID is pleased to play a leading role in the implementation of President Obama's vision for global development.
Contrast-enhanced ultrasound is an effective, noninvasive method for monitoring patients who undergo endovascular repair for abdominal aortic aneurysms, according to a new study published in the journal Radiology.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
Cleveland Clinic researchers have identified a cellular pathway that cancer stem cells use to promote tumor growth in malignant glioma, an aggressive brain tumor.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Gerodias, LMHC TEMP, CADC 3320 W 4th St, Sioux City, IA 51103-3200 Ph: (712) 202-0777 | Andrew Gerodias, LMHC TEMP, CADC 3320 W 4th St, Sioux City, IA 51103-3200 Ph: (712) 202-0777 |
News Archive
Driven by increasing demand from drug and medical device developers for cost-effective and user-friendly data analytics tools, Comprehend Systems, Inc. closed $1.2 million in seed round funding to support further development of Comprehend Clinical, its clinical data visualization and analytics software.
"From President John F. Kennedy to President Barack Obama, the United States has a rich history of providing assistance that improves the lives of men, women and children around the globe. Today President Obama issued the first-ever development policy by a U.S. President. In partnership with the host countries where we work, USAID is pleased to play a leading role in the implementation of President Obama's vision for global development.
Contrast-enhanced ultrasound is an effective, noninvasive method for monitoring patients who undergo endovascular repair for abdominal aortic aneurysms, according to a new study published in the journal Radiology.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
Cleveland Clinic researchers have identified a cellular pathway that cancer stem cells use to promote tumor growth in malignant glioma, an aggressive brain tumor.
› Verified 9 days ago
Roxann Smith, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 800 5th St, Sioux City, IA 51101 Phone: 712-234-2323 Fax: 712-234-2399 | |
Megan Marie Ohlendorf, TCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 800 5th St Ste 200, Sioux City, IA 51101 Phone: 712-234-2300 | |
Mrs. Pamela A Kumpf, LBSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 705 Douglas St, Suite 350, Sioux City, IA 51101 Phone: 712-277-8991 Fax: 712-277-8991 | |
Natalie Christopherson, LMHC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: #1012, 5001 Sergeant Road Suite 50, Sioux City, IA 51106 Phone: 402-403-2800 | |
Ms. Cynthia Pelton, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 520 14th St, Sioux City, IA 51105 Phone: 712-252-7170 Fax: 712-252-7173 | |
Rosanna Marie Jovanovic, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1221 Pierce St, Sioux City, IA 51105 Phone: 712-255-0204 | |
Theodore Daniel Hostikka, M.S., LADC, IADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3500 W 4th St, Sioux City, IA 51103 Phone: 712-226-1899 |